Patent ID: 9265741
Filing Date: 2016-02-23
CPC Classification: A61K

Claim Text:
1. A method of treating a patient afflicted with Diabetes Mellitus to reduce HbA1c of said patient, wherein energy is provided to energy deprived cells of said patient, said method consisting of the steps of: a) administering, to said patient afflicted with said Diabetes Mellitus, respective therapeutically effective amounts of methyl pyruvate and at least one lipophilic alkyl analog of said methyl pyruvate at least once a week, so as to provide said energy to said energy deprived cells via a citric acid cycle in said cells and so as to reduce said HbA1c of said patient; b) administering at least one additional agent together with said respective therapeutically effective amounts of said methyl pyruvate and said at least one lipophilic alkyl analog of said methyl pyruvate; and c) monitoring glucose concentration of said patient suffering from said Diabetes Mellitus during said administration; wherein said at least one additional agent is selected from the group consisting of alpha-lipoic acid, acetyl L-carnitine, taurine, inosine, magnesium chloride, magnesium L-threonate, medium chain triglycerides, vitamin E in the form of alpha and gamma tocopherol, vitamin D3 and niacin.